Overview

OSU researchers have developed a biodegradable polymer materials platform that addresses long standing limitations in conventional biomedical polymers by enabling intrinsic control over crystallinity, degradation, and performance, reducing reliance on downstream formulation compromises that add cost, risk, and variability in regulated medical and drug delivery applications.

The Opportunity

This technology introduces a new approach to biodegradable materials design by shifting performance control upstream to the polymer chemistry itself, enabling manufacturers to achieve reliable, application specific material behavior without increasing formulation complexity. The result is a scalable, customizable platform that supports faster development cycles, stronger product differentiation, and improved lifecycle consistency across high value biomedical markets.

Key Advantages

• Built in Performance Control: Polymer properties are engineered at the molecular level, reducing dependence on additives, blends, and post processing adjustments.
• Enhanced Reproducibility: Consistent material behavior across batches improves manufacturing reliability and scale up confidence.
• Platform Flexibility: A single core chemistry supports multiple polymer variants tailored to different applications and performance profiles.
• Manufacturing Continuity: Compatibility with standard polymerization and processing methods minimizes disruption to existing workflows.
• Stronger Materials Differentiation: Composition based innovation enables more defensible product positioning and IP strategies.

Transform Your Biomedical Materials Pipeline

Move beyond incremental formulation workarounds and adopt a materials platform designed for predictability, scalability, and long-term value creation. This technology empowers biomedical and pharmaceutical companies to accelerate innovation, reduce development risk, and deliver next generation biodegradable products with greater confidence and efficiency.

Contact an Ohio State Licensing Officer at Innovation & Commercialization to explore licensing or collaborative development opportunities.